New Virus Drug Will Have To Shoot At Moving Targets
Main Category: Liver Disease / HepatitisArticle Date: 20 Oct 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (3 votes) |
| Healthcare Prof: | ![]() |
The reproduction of the deadly hepatitis B virus is dependent on the mobility of one of the virus's RNAs. This is shown by Katja Petzold and Jurgen Schleucher, Umea University, Sweden, in an article in the latest issue of the journal Nucleic Acids Research.
More than 300 million people all over the world are infected by hepatitis B virus (HBV), and there are 2 million deaths per year. The Umea researchers have studied the mobility of the virus's RNA, a property that is necessary for HBV to reproduce. Besides Jurgen Schleucher and Katja Petzold, Karin Kidd-Ljunggren of Lund University in Sweden and Sybren Wijmenga of Nijmegen University in Holland are co-authors of the article.
The structures of proteins and nucleic acids are usually presented as still images. However, the molecules' functions or interactions with drugs are dependent on structural changes, and it is possible to reach only indirect conclusions about these on the basis of still images. Nuclear Magnetic Resonance (NMR) is the only technology that enables studies of movements in specific parts of molecules. With the aid of NMR, the relationship between the movement and function of molecules has been mapped for many proteins, but only for a few nucleic acids. This is unfortunate, especially because several new classes of RNA with regulatory functions have recently been discovered. This means that RNA is now regarded to an even greater extent as an active regulator of cellular events, not merely a passive messenger for information.
When new HBV particles are formed in infected cells, the virus must translate RNA to DNA, a process that is called reverse transcription. It starts with the virus enzyme reverse transcriptase binding to a strongly conserved RNA structure in the virus. The authors found that fully conserved nucleotides (the building blocks of RNA) in this RNA evince striking patterns of mobility. This indicates that these nucleotides in the free RNA temporarily visit the structures that they use in complexes with reverse transcriptases, and that their mobility facilitates binding. This means that drugs directed toward the hepatitis virus RNA need to bind to a moving target.
These detailed findings are based on the first application of a new NMR method that was developed at Umea University. The new method enables studies of movements in the bindings in the RNA molecule that give it its form. The method can also be used for complex bindings between drug candidates and proteins or nucleic acids in order to elucidate the stabilizing forces at the atomic level. Therefore, this can be a key tool in biotechnology and the discovery of new drugs. The research team is now moving on to computer simulations to produce images of the movements in an RNA.
VETENSKAPSRADET (THE SWEDISH RESEARCH COUNCIL)
Regeringstgatan 56
103 78 Stockholm
http://www.vr.se
Visit our liver disease / hepatitis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/86155.php>
APA
http://www.medicalnewstoday.com/releases/86155.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




